A father smiles at his young daughter as he holds her up.
 

Get ready for ESCMID Global 2025

Did you know? Beckman Coulter and Cepheid are part of Danaher Diagnostics.

Together, we are focused on solving complex health challenges for patients around the world, enabling healthcare providers to diagnose diseases with unprecedented speed and precision.

 

Every moment matters when lives are at stake. There’s no time to wait.  

Join us at booth #E10 to explore our cutting-edge diagnostic tools and attend insightful presentations.

 

 

Be Part of Our In-Booth Experience:

12 April 2025
10:40 — 10:55

 

Decoding the host: revolutionizing infection diagnostics
Joachim Reischl, Vice President, External Innovation Diagnostics, Danaher Diagnostics
Ephraim Tsalik, Vice President and Chief Scientific Officer - Infectious Disease, Danaher Diagnostics

 

12 April 2025
15:50 — 16:05

 

Use of multiplex PCR in general practitioners offices: feasibility and medical impact assessment in a randomized prospective study in Germany
Scientist Tobias Tuschscherer, University Hospital Leipzig, Germany 

13 April 2025
10:40 — 10:55

 

GBS intrapartum testing: clinical impact on mothers and newborns
Dr. Najoua El Helali, Microbiologist, Maternity Referent and GBS Expert, Medical Manager of antimicrobial dosage,
Hôpital Saint-Joseph/ Marie-Lannelongue, Paris 

 

13 April 2025
15:50 — 16:05

Case study – automated AST and plate streaking workflow and their role in increased efficiencies in the microbiology laboratory
Dr. Mahmoud Gargouri, Biologiste Medical Co-Responsible, Bio-VSM Lab, Autoplak Reference Lab, Torcy, France

 

CEPHEID INTEGRATED SYMPOSIUM

Expert Insights on Diagnostics and Antimicrobial Resistance

14 April 2025 from 13:30 to 15:30 
Hall 6

Chair: Dr. Devasena Gnanashanmugam, Vice President, Medical Affairs, Cepheid, USA 
ESCMID-appointed Chair: Pr. Laurent Dortet, Hôpital de Bicêtre, France

 
 

Urgency in Combating AMR: The Critical Role of Molecular and Rapid Diagnostics for Actionable Outcome

Pr. Alison Holmes

Professor Alison Holmes, Professor of Infectious Diseases, Imperial College, The David Price Evans Chair of Global Health and Infectious Diseases, University of Liverpool, and Director of the  Fleming Initiative, Imperial College London

 

Rapid Respiratory Testing: Experience of POC and laboratory molecular testing in a large teaching hospital Trust

Dr. Nick Machin

Consultant Virologist, Manchester University Foundation Trust, UK

 

The Kentucky Viral Hepatitis Treatment (KeY Treat) Trial: A Model of Care in a Rural Appalachian County, U.S.

Dr. Jennifer R. Havens 

Infectious disease epidemiologist and Professor in the Department of Behavioral Science, University of Kentucky College of Medicine (UKCOM), USA

 

Antimicrobial Resistance, an Update from the Middle East

Dr. Mohammed Al Zunitan

Deputy Executive Director, Infection Prevention and Control Program, King Abdulaziz Medical City, Ministry of National Guard Health Affairs, KSA

 

Impact of Carbapenemase-PCR in Outbreak Management — Cost vs. Benefit

PD Dr. Thomas Bollinger

Institute Director, Specialist in Microbiology, Virology and Infection Epidemiology Specialist Immunologist, Deutschen Gesellschaft für Immunologie (DGFI), Germany

 

 

CE-IVD. In Vitro Diagnostic Medical Device. May not be available in all countries.

Register now !

Add to your calendar our in-booth presentations, integrated symposium and posters sessions.

I would like to be part of the Cepheid Community and I understand and consent to receive information about products and services, invitations to virtual and in-person events such as workshops and webinars and educational content from Cepheid and similar information from Cepheid’s affiliates and representatives.

*required fields
Cepheid respects your privacy, and values the relationship with our customers, partners, and associates. Your personal data may be processed by Cepheid, its affiliates, representatives and other Danaher companies for business and marketing purposes. You can review Cepheid Privacy Policy online for additional information on your rights and how we use and share personal data we collect on our websites and other channels. Your consent to receiving Cepheid news can be withdrawn at any time. Building a relationship of trust is important to us and we will happily help with any questions on your personal data processing addressed to Privacy.officer@cepheid.com

About Cepheid

Cepheid is dedicated to improving healthcare by pioneering molecular diagnostics that combine speed, accuracy, and flexibility. The company's GeneXpert® systems and Xpert® tests automate highly complex and time-consuming manual procedures, providing A Better Way for institutions of any size to perform world-class PCR testing. Cepheid's broad test portfolio spans respiratory infections, blood virology, women's and sexual health, TB and emerging infectious diseases, healthcare-associated infectious diseases, oncology and human genetics. The company's solutions deliver actionable results where they are needed most from central laboratories and hospitals to near patient settings.

For more information, visit www.cepheid.com

© 2025 Beckman Coulter, Inc. All rights reserved. Beckman Coulter, the stylized logo, and the Beckman Coulter product and service marks mentioned herein are trademarks or registered trademarks of Beckman Coulter, Inc. in the United States and other countries. The Danaher trademark is a proprietary mark of Danaher Corporation. All other trademarks are the property of their respective owners.

©2025 Cepheid. All Rights Reserved.